Literature DB >> 20599538

P70S6K 1 regulation of angiogenesis through VEGF and HIF-1alpha expression.

Chuan-Xiu Bian1, Zhumei Shi, Qiao Meng, Yue Jiang, Ling-Zhi Liu, Bing-Hua Jiang.   

Abstract

The 70kDa ribosomal S6 kinase 1 (p70S6K1), a downstream target of phosphoinositide 3-kinase (PI3K) and ERK mitogen-activated protein kinase (MAPK), is an important regulator of cell cycle progression, and cell proliferation. Recent studies indicated an important role of p70S6K1 in PTEN-negative and AKT-overexpressing tumors. However, the mechanism of p70S6K1 in tumor angiogenesis remains to be elucidated. In this study, we specifically inhibited p70S6K1 activity in ovarian cancer cells using vector-based small interfering RNA (siRNA) against p70S6K1. We found that knockdown of p70S6K1 significantly decreased VEGF protein expression and VEGF transcriptional activation through the HIF-1alpha binding site at its enhancer region. The expression of p70S6K1 siRNA specifically inhibited HIF-1alpha, but not HIF-1beta protein expression. We also found that p70S6K1 down-regulation inhibited ovarian tumor growth and angiogenesis, and decreased cell proliferation and levels of VEGF and HIF-1alpha expression in tumor tissues. Our results suggest that p70S6K1 is required for tumor growth and angiogenesis through HIF-1alpha and VEGF expression, providing a molecular mechanism of human ovarian cancer mediated by p70S6K1 signaling. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599538      PMCID: PMC2928061          DOI: 10.1016/j.bbrc.2010.06.080

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

Review 1.  Coordinate regulation of translation by the PI 3-kinase and mTOR pathways.

Authors:  Kathleen A Martin; John Blenis
Journal:  Adv Cancer Res       Date:  2002       Impact factor: 6.242

Review 2.  Angiogenesis as a biomarker and target in cancer chemoprevention.

Authors:  R A Sharma; A L Harris; A G Dalgleish; W P Steward; K J O'Byrne
Journal:  Lancet Oncol       Date:  2001-12       Impact factor: 41.316

3.  Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.

Authors:  Markus Guba; Philipp von Breitenbuch; Markus Steinbauer; Gudrun Koehl; Stefanie Flegel; Matthias Hornung; Christiane J Bruns; Carl Zuelke; Stefan Farkas; Matthias Anthuber; Karl-Walter Jauch; Edward K Geissler
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

4.  Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.

Authors:  H Zhong; K Chiles; D Feldser; E Laughner; C Hanrahan; M M Georgescu; J W Simons; G L Semenza
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

5.  Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.

Authors:  B H Jiang; G Jiang; J Z Zheng; Z Lu; T Hunter; P K Vogt
Journal:  Cell Growth Differ       Date:  2001-07

6.  An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice.

Authors:  K Podsypanina; R T Lee; C Politis; I Hennessy; A Crane; J Puc; M Neshat; H Wang; L Yang; J Gibbons; P Frost; V Dreisbach; J Blenis; Z Gaciong; P Fisher; C Sawyers; L Hedrick-Ellenson; R Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

7.  Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

Authors:  M S Neshat; I K Mellinghoff; C Tran; B Stiles; G Thomas; R Petersen; P Frost; J J Gibbons; H Wu; C L Sawyers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

8.  A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.

Authors:  A Sekulić; C C Hudson; J L Homme; P Yin; D M Otterness; L M Karnitz; R T Abraham
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

9.  Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.

Authors:  Christine C Hudson; Mei Liu; Gary G Chiang; Diane M Otterness; Dawn C Loomis; Fiona Kaper; Amato J Giaccia; Robert T Abraham
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

10.  Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells.

Authors:  Ryo Fukuda; Kiichi Hirota; Fan Fan; Young Do Jung; Lee M Ellis; Gregg L Semenza
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

View more
  30 in total

1.  Loss of SNAIL inhibits cellular growth and metabolism through the miR-128-mediated RPS6KB1/HIF-1α/PKM2 signaling pathway in prostate cancer cells.

Authors:  Tao Tao; Guifang Li; Qingsheng Dong; Dachuang Liu; Chunhui Liu; Dongfeng Han; Yeqing Huang; Shuqiu Chen; Bin Xu; Ming Chen
Journal:  Tumour Biol       Date:  2014-05-25

2.  Emodin alleviated pulmonary inflammation in rats with LPS-induced acute lung injury through inhibiting the mTOR/HIF-1α/VEGF signaling pathway.

Authors:  Xiaoqian Li; Cong Shan; Zhonghua Wu; Hongji Yu; Aidong Yang; Bo Tan
Journal:  Inflamm Res       Date:  2020-03-04       Impact factor: 4.575

3.  Minocycline attenuates hypoxia-inducible factor-1α expression correlated with modulation of p53 and AKT/mTOR/p70S6K/4E-BP1 pathway in ovarian cancer: in vitro and in vivo studies.

Authors:  Parvin Ataie-Kachoie; Mohammad H Pourgholami; Farnaz Bahrami-B; Samina Badar; David L Morris
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

Review 4.  Diverse mechanisms of AKT pathway activation in human malignancy.

Authors:  Mitchell Cheung; Joseph R Testa
Journal:  Curr Cancer Drug Targets       Date:  2013-03       Impact factor: 3.428

5.  Bioinformatic analysis reveals a pattern of STAT3-associated gene expression specific to basal-like breast cancers in human tumors.

Authors:  Robert W Tell; Curt M Horvath
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-19       Impact factor: 11.205

6.  Dietary compounds galangin and myricetin suppress ovarian cancer cell angiogenesis.

Authors:  Haizhi Huang; Allen Y Chen; Yon Rojanasakul; Xingqian Ye; Gary O Rankin; Yi Charlie Chen
Journal:  J Funct Foods       Date:  2015-05-01       Impact factor: 4.451

7.  miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.

Authors:  Chao Cai; Qing-Biao Chen; Zhao-Dong Han; Yan-Qiong Zhang; Hui-Chan He; Jia-Hong Chen; Yan-Ru Chen; Sheng-Bang Yang; Yong-Ding Wu; Yan-Ru Zeng; Guo-Qiang Qin; Yu-Xiang Liang; Qi-Shan Dai; Fu-Neng Jiang; Shu-lin Wu; Guo-Hua Zeng; Wei-De Zhong; Chin-Lee Wu
Journal:  Clin Cancer Res       Date:  2015-06-16       Impact factor: 12.531

8.  Rapamycin inhibits proliferation of hemangioma endothelial cells by reducing HIF-1-dependent expression of VEGF.

Authors:  Damian Medici; Bjorn R Olsen
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

Review 9.  Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.

Authors:  Wanli Yu; Sai Liang; Chunzhi Zhang
Journal:  Neuromolecular Med       Date:  2018-09-04       Impact factor: 3.843

10.  Translational suppression of HIF-1α by miconazole through the mTOR signaling pathway.

Authors:  Jee-Young Park; Hui-Jung Jung; Incheol Seo; Bijay Kumar Jha; Seong-Il Suh; Min-Ho Suh; Won-Ki Baek
Journal:  Cell Oncol (Dordr)       Date:  2014-07-29       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.